Pituitary Apoplexy Induced by Anticoagulant Therapy in Patient with Acute Coronary Syndrome

Laporan Kasus

Penulis

  • Michael Johan Dokter Umum, Rumah Sakit Mitra Keluarga Kemayoran
  • Handry Pangestu Departemen Penyakit Dalam, Rumah Sakit Mitra Keluarga Kemayoran

DOI:

https://doi.org/10.55175/cdk.v51i7.1023

Kata Kunci:

Antikoagulan, apopleksi, tumor hipofisis

Abstrak

Apopleksi hipofisis didefinisikan sebagai perdarahan atau infark kelenjar hipofisis, dapat terjadi pada tumor hipofisis yang belum terdiagnosis. Beberapa mekanisme yang diduga memicu apopleksi hipofisis adalah fluktuasi tekanan darah, stimulasi hormonal pada kelenjar hipofisis, gangguan koagulasi, atau gangguan vaskular. Kasus laki-laki, berusia 73 tahun, warga negara India, dengan keluhan nyeri dada sejak 4 jam yang lalu. Pemeriksaan elektrokardiografi (EKG) dan laboratorium mengarah pada sindrom koroner akut (SKA). Pasien diberi fondaparinux, aspirin, dan clopidogrel. Pada hari ke-4 perawatan pasien nyeri kepala berat, muntah menyembur, dan pandangan ganda. Pemeriksaan radiologis menunjukkan tumor hipofisis dengan tanda-tanda perdarahan tersebar yang mengkompresi kiasma optik, menunjukkan apopleksi tumor hipofisis. Pemeriksaan fungsi hormon menunjukkan tumor hipofisis yang tidak mensekresi hormon. Pengencer darah dihentikan kemudian diberi vitamin K dan dexamethasone. Setelah beberapa hari, nyeri kepala dan pandangan ganda membaik. Pemeriksaan MRI kepala ulang mendapatkan massa tetap dan perdarahan tidak bertambah. Tumor hipofisis bisa menjadi kontraindikasi relatif penggunaan antiplatelet ganda dan antikoagulan pada sindrom koroner akut, terutama pada kelompok komorbiditas penyakit ginjal atau hati.

Unduhan

Data unduhan belum tersedia.

Biografi Penulis

Handry Pangestu, Departemen Penyakit Dalam, Rumah Sakit Mitra Keluarga Kemayoran

Internal Medicine Department

Referensi

Capatina C, Inder W, Karavitaki N, Wass JAH. Management of endocrine disease: Pituitary tumour apoplexy. Eur J Endocrinol. 2015;172(5):R179-90.

Ranabir S, Baruah MP. Pituitary apoplexy. Indian J Endocrinol Metab. 2011;15:S188-96.

Fernandez A, Karavitaki N, Wass JAH. Prevalence of pituitary adenomas: A community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol. 2010;72(3):377–82.

Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary apoplexy. Endocr Rev. 2015;36(6):622–45.

Tansel T, Ugurlucan M, Onursal E. Pituitary apoplexy following coronary artery bypass grafting report of a case. Acta Chir Belg. 2010;110(4):484–6.

Kılıclı F, Dokmetas H, Gurelik M. Development of pituitary apoplexy during TRH/GnRH test in a patient with pituitary macroadenoma. Singapore Med J. 2010;51:e179-81.

Uemura M, Miyashita F, Shimomura R, Fujinami J, Toyoda K. Pituitary apoplexy during treatment with dabigatran. Neurol Clin Neurosci. 2013;1(2):82–3.

Kumar V, Kataria R, Mehta V. Dengue hemorrhagic fever: A rare cause of pituitary tumor hemorrhage and reversible vision loss. Indian Journal of Ophtalmology. 2011;59:311–2.

Di Ieva A, Weckman A, Di Michele J, Rotondo F, Grizzi F, Kovacs K, et al. Microvascular morphometrics of the hypophysis and pituitary tumors: From bench to operating theatre. Microvasc Res. 2013;89:7–14.

Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. New England Journal of Medicine 1983;309(7):396–403.

Singh D, Gupta K, Vacek JL. Anticoagulation and antiplatelet therapy in acute coronary syndromes. Cleve Clin J Med. 2014;81(2):103–14.

Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes. Circulation 2014;130(25):e344–426.

Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med. 2006;354(14):1464–76.

Tersalvi G, Biasco L, Cioffi GM, Pedrazzini G. Acute coronary syndrome, antiplatelet therapy, and bleeding: A clinical perspective. J Clin Med. 2020;9(7):2064-83.

Donat F, Duret JP, Santoni A, Cariou R, Necciari J, Magnani H, et al. The pharmacokinetics of fondaparinux sodium in healthy volunteers. Clin Pharmacokinet. 2002;41(2):1–9.

Vicente A, Lecumberri B, Galvez MA. Clinical practice guideline for the diagnosis and treatment of pituitary apoplexy. Endocrinol Nutr. 2013;60(10):582.e1-582.e12.

Santos AR, Bello CT, Sousa A, Duarte JS, Campos L. Pituitary apoplexy following systemic anticoagulation. Vol. 6, European journal of case reports in internal medicine. Italy; 2019. p. 1254.

Mudalagiri M, Ayyar V, Bantwal G, George B, Appaiah S. The pituitary apoplexy score (PAS) in the evaluation and management of pituitary apoplexy: A single centre experience. Indian J of Endocrinol and Metab. 2022;26:S37.

Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf ). 2011;74(1):9–20.

Fan Y, Bao X, Wang R. Conservative treatment cures an elderly pituitary apoplexy patient with oculomotor paralysis and optic nerve compression: A case report and systematic review of the literature. Clin Interv Aging 2018;13:1981–5.

Diterbitkan

2024-07-01

Cara Mengutip

Johan, M., & Pangestu, H. (2024). Pituitary Apoplexy Induced by Anticoagulant Therapy in Patient with Acute Coronary Syndrome: Laporan Kasus. Cermin Dunia Kedokteran, 51(7), 396–399. https://doi.org/10.55175/cdk.v51i7.1023

Terbitan

Bagian

Articles